As expected, the head of New Mexico’s Department of Health approved opioid use disorder as a qualifying condition to use medical cannabis. In an announcement on Thursday, DOH Secretary Kathyleen Kunkel said she accepted a recommendation from the state’s Medical Cannabis Advisory Board to include opioid use disorder and five other conditions as reasons to grant a medical card for medical cannabis use. “Adding these conditions to the Medical Cannabis Program provides medical providers new tools for relieving symptoms that may otherwise be difficult, if not impossible in some cases, to relieve through conventional means,” Kunkel said in a statement. “Thousands of New Mexicans may find relief from their symptoms through medical cannabis that they can’t get anywhere else.”
Kunkel also approved Alzheimer’s disease, autism spectrum disorder and three degenerative neurological disorders—Friedreich’s ataxia, Lewy body disease, and spinal muscular atrophy. The approval of those six conditions is the latest change in the Medical Cannabis Program since the change in administrations.
The New Mexico Department of Health confirmed the state’s first case of measles in nearly five years. Last week, DOH said a one-year-old child from Sierra County is the first New Mexican infected with the disease since December of 2014. “We have worked with the clinic that treated the child and the patient’s family to identify people who may have been exposed so we can prevent more cases of the disease,” DOH Secretary Kathyleen Kunkel announced Friday. “We encourage everyone to check whether you and your family have been vaccinated to protect against measles. Immunization is the best tool we have to protect people from measles.”
Measles is highly infectious and was considered eliminated in the United States in 2000, thanks to the development of a vaccine in the 1960s and a concerted effort by the Centers for Disease Control beginning in the late 1970s.
The New Mexico Department of Health (DOH) has until August to decide how much medical cannabis producers are allowed to grow at any given time. Until recently, Licensed Non-Profit Producers (LNPP) could have up to 450 plants, but in March the state issued an emergency rule allowing producers to grow five times that amount—or up to 2,500 plants—after a drawn-out lawsuit. Public records obtained by NM Political Report reveal some of the discussions between producers, patients and Gov. Michelle Lujan Grisham’s office during the days leading up to the emergency rule. Many of those conversations were redacted due to executive and attorney-client privilege. But, the documents still shed light on the decision by DOH Secretary Kathyleen Kunkel to temporarily increase the plant counts.
A medical advisory panel on Friday said, for the third time, opioid use disorder should be a qualifying condition for medical cannabis—but this time the cabinet secretary tasked with final approval is expected to agree. The New Mexico Medical Cannabis Advisory Board voted unanimously to add opioid addiction to the list of 22 conditions already allowed. Only four other states allow patients to use cannabis to help alleviate symptoms of opioid use disorder. Dr. Laura Brown, the board’s chair, signaled that the Department of Health is changing course when it comes to medical cannabis under newly appointed Secretary Kathyleen Kunkel. A Medical Cannabis Advisory Board meeting on March 29, 2019.